Cargando…
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary
The approval and adoption of biosimilar products are essential to contain increasing healthcare costs and provide more affordable choices for patients. Despite steady progress in the number of the US Food and Drug Administration (FDA) biosimilar approvals over the years, biosimilar adoption in the U...
Autores principales: | Shubow, Sophie, Sun, Qin, Nguyen Phan, Ai Len, Hammell, Dana C., Kane, Maureen, Lyman, Gary H., Gibofsky, Allan, Lichtenstein, Gary R., Bloomgarden, Zachary, Cross, Raymond K., Yim, Sarah, Polli, James E., Wang, Yow‐Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099086/ https://www.ncbi.nlm.nih.gov/pubmed/36251545 http://dx.doi.org/10.1002/cpt.2765 |
Ejemplares similares
-
Biosimilar insulin concepts
por: Bloomgarden, Zachary T.
Publicado: (2022) -
US rheumatologists’ beliefs and knowledge about biosimilars: a survey
por: Gibofsky, Allan, et al.
Publicado: (2020) -
An online survey among US patients with immune-mediated conditions: Attitudes about biosimilars
por: Gibofsky, Allan, et al.
Publicado: (2023) -
Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab
por: Feagan, Brian G., et al.
Publicado: (2018) -
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
por: Niazi, Sarfaraz K
Publicado: (2023)